Between 1988 and 1998, antibody-associated pure red-cell aplasia was reported in three patients who had undergone treatment with recombinant human erythropoietin (epoetin). Between 1998 and 2000, 13 ...
Dec. 9, 2004 -- The U.S. Food and Drug Administration (FDA) and Ortho Biotech Products warned healthcare professionals via letter of important information regarding the safe dosing of epoetin alfa ...
Patients were considered for inclusion in the study if they were ≥70 years of age and were having elective TKA or THA. The study group and control group were matched as closely as possible for age, ...
BRIDGEWATER, N.J., March 7 /PRNewswire/ -- Ortho Biotech Products, L.P. today modified prescribing information for PROCRIT(R) (Epoetin alfa), following guidance from the U.S. Food and Drug ...
Gaithersburg, MD (September 11, 2007) – As the Food and Drug Administration (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC) and Drug Safety and Risk Management Advisory Committee ...
BRIDGEWATER, N.J., Nov. 8 Ortho BiotechProducts, L.P. today modified prescribing information for PROCRIT(R) (Epoetinalfa), following guidance from the U.S. Food and Drug Administration (FDA) torevise ...
The US Food and Drug Administration has approved Pfizer’s Retacrit, a biosimilar of Amgen's Epogen and Johnson & Johnson's Procrit. The US Food and Drug Administration has approved Pfizer’s Retacrit, ...
THOUSAND OAKS, Calif., Sept. 24 /PRNewswire/ -- Amgen (Nasdaq: AMGN) announced today that certain lots of EPOGEN® and PROCRIT® (Epoetin alfa) vials are being voluntarily recalled from specialty ...
Hospitals and pharmacies may have unknowingly bought a counterfeit version of the anti-anemia drug Procrit — and the useless product also is contaminated with bacteria, the government warned Tuesday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results